Alcohol withdrawal follows a clinically predictable timeline that begins 6 to 12 hours after the last drink and can last up to two weeks in severe cases. Symptoms range from anxiety and tremors in the early hours to potentially life-threatening seizures and delirium tremens (DTs) between 48 and 96 hours. The severity depends on drinking history, previous withdrawal episodes, and individual physiology. Medically supervised detoxification using benzodiazepine protocols and the CIWA-Ar scoring system is the standard of care for moderate to severe withdrawal.
A Physician’s Perspective on Withdrawal
“Alcohol withdrawal is one of the few substance withdrawal syndromes that can be fatal,” says Dr. Ponlawat Pitsuwan, Physician, Phuket Island Rehab. “I have managed hundreds of detoxifications, and the pattern is remarkably consistent. What varies is severity, and that is where clinical assessment tools like the CIWA-Ar become essential. A patient scoring 8 needs reassurance and monitoring. A patient scoring 20 needs immediate pharmacological intervention. The difference between those two responses can be the difference between a safe detox and a medical emergency.”
Why Alcohol Withdrawal Happens
To understand the withdrawal timeline, it helps to understand the neurochemistry behind it. Chronic alcohol use suppresses the brain’s excitatory glutamate system while enhancing the inhibitory GABA system. Over time, the brain compensates by upregulating glutamate (NMDA) receptors and downregulating GABA-A receptors to maintain a functional balance. When alcohol is suddenly removed, this compensatory state is unmasked: excitatory signalling spikes while inhibitory capacity is depleted. The result is a hyperexcitable nervous system that produces the cascade of symptoms known as alcohol withdrawal syndrome (AWS).
This neuroadaptation also explains the kindling phenomenon, where each successive withdrawal episode tends to be more severe than the last. Previous detoxifications are a critical risk factor that clinicians assess before beginning any withdrawal management protocol. Individuals with three or more prior withdrawal episodes face significantly higher seizure risk, even if their current drinking levels are lower than before.
The Withdrawal Timeline: Hour by Hour
6 to 12 Hours: Early Symptoms
The earliest withdrawal symptoms typically emerge within 6 to 12 hours after the last drink, sometimes sooner in individuals with severe dependence. This phase is characterised by anxiety, restlessness, irritability, insomnia, nausea, mild tremor in the hands, increased heart rate, and elevated blood pressure. Many people mistake these early symptoms for a severe hangover, which can delay appropriate medical care. The key differentiator is that hangover symptoms improve over hours, while withdrawal symptoms progressively worsen.
During this phase, autonomic hyperactivity begins as the sympathetic nervous system activates in response to the loss of alcohol’s depressant effects. Diaphoresis (sweating), particularly nocturnal sweating, is common. Gastrointestinal distress including nausea, vomiting, and anorexia reflects both autonomic instability and direct irritation of the gastric mucosa from chronic alcohol exposure.
12 to 24 Hours: Alcoholic Hallucinosis
Between 12 and 24 hours, some individuals develop alcoholic hallucinosis, a condition distinct from delirium tremens. Patients may experience visual, auditory, or tactile hallucinations while remaining oriented and aware that the perceptions are not real. Visual hallucinations often involve small moving objects or insects (formication), while auditory hallucinations may include indistinct voices or sounds. Importantly, the patient’s sensorium remains clear during alcoholic hallucinosis, meaning they know where they are, what day it is, and can engage in conversation. This preserved orientation distinguishes hallucinosis from the global confusion of DTs.
24 to 48 Hours: Peak Autonomic Instability and Seizure Risk
The 24 to 48 hour window represents the period of greatest autonomic instability for most patients. Tremors may become coarse and generalised, heart rate and blood pressure rise further, and the patient may develop a low-grade fever. This is also the period of highest seizure risk. Alcohol withdrawal seizures are typically brief, generalised tonic-clonic events that occur in clusters of two to three. Approximately 3 to 5% of individuals undergoing withdrawal will experience seizures, with the risk rising substantially in those with previous withdrawal seizures or concurrent benzodiazepine withdrawal.
Seizures during this window are driven by glutamate excitotoxicity: unopposed NMDA receptor activation causes excessive neuronal firing. This is why benzodiazepines, which enhance GABA-A receptor function, are the first-line pharmacological treatment. They directly address the underlying GABA deficit that triggers seizure activity.
48 to 96 Hours: Delirium Tremens
Delirium tremens represents the most severe and dangerous manifestation of alcohol withdrawal, occurring in approximately 3 to 5% of hospitalised withdrawal patients. DTs typically emerge between 48 and 96 hours after the last drink, though onset can be delayed up to 7 days in unusual cases. The syndrome is characterised by global confusion, disorientation, agitation, vivid hallucinations (often terrifying), severe autonomic instability (tachycardia above 120 bpm, hypertension, hyperthermia above 38.3 degrees Celsius), and profound diaphoresis. Unlike alcoholic hallucinosis, patients with DTs have a clouded sensorium and cannot distinguish hallucinations from reality.
Without treatment, DTs carry a mortality rate of up to 37%. With modern intensive care and appropriate benzodiazepine management, mortality has been reduced to 1 to 4%, but it remains a genuine medical emergency. Risk factors for developing DTs include a history of previous DTs, age over 40, concurrent acute illness, elevated heart rate at presentation, CIWA-Ar score above 20, and a history of sustained heavy drinking (typically more than 10 years).
| Timeline | Symptoms | Severity | Clinical Response |
|---|---|---|---|
| 6 to 12 hours | Anxiety, tremor, nausea, insomnia, sweating, tachycardia | Mild | CIWA-Ar monitoring, supportive care, thiamine |
| 12 to 24 hours | Hallucinations (visual, auditory, tactile) with clear sensorium | Moderate | Symptom-triggered benzodiazepines if CIWA-Ar ≥ 10 |
| 24 to 48 hours | Peak tremors, seizure risk, autonomic instability, fever | Severe | Benzodiazepine protocol, seizure precautions, IV fluids |
| 48 to 96 hours | Delirium tremens: confusion, agitation, vivid hallucinations, hyperthermia | Life-threatening | ICU-level care, high-dose benzodiazepines, continuous monitoring |
| 5 to 14 days | Gradual resolution, residual anxiety, insomnia, mood instability | Improving | Taper medications, begin psychosocial treatment, nutritional support |
The CIWA-Ar Assessment Tool
The Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar) is the gold standard tool for monitoring withdrawal severity. It scores 10 domains including nausea, tremor, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache, orientation, and paroxysmal sweats on a scale from 0 to 67. Scores below 10 indicate mild withdrawal manageable with supportive care. Scores of 10 to 18 suggest moderate withdrawal requiring pharmacological intervention. Scores above 20 indicate severe withdrawal with high risk for complications including seizures and DTs.
The advantage of CIWA-Ar-based symptom-triggered therapy over fixed-schedule dosing is that it delivers benzodiazepines only when the patient needs them, reducing total medication exposure, shortening detoxification duration, and lowering the risk of oversedation. Studies comparing symptom-triggered to fixed-dose protocols consistently show that symptom-triggered regimens use 50 to 70% less medication while achieving equivalent or superior outcomes.
Post-Acute Withdrawal Syndrome (PAWS)
After the acute withdrawal period resolves, many individuals experience a protracted phase known as post-acute withdrawal syndrome. PAWS can persist for weeks to months and includes symptoms such as persistent anxiety, mood swings, irritability, fatigue, sleep disturbances, difficulty concentrating, and reduced stress tolerance. These symptoms reflect the brain’s ongoing neurochemical rebalancing as GABA and glutamate systems gradually normalise and dopamine function recovers.
PAWS is clinically significant because it is a major driver of early relapse. Patients who are not warned about protracted symptoms may interpret them as evidence that something is permanently wrong, leading to discouragement and return to drinking. At Phuket Island Rehab’s alcohol detox programme, patients receive education about PAWS during treatment so they can recognise these symptoms as temporary signs of recovery rather than reasons to relapse.
When Drinking Has Become More Than Occasional
If you experience withdrawal symptoms when you stop drinking, even mild ones like morning anxiety, hand tremors, or night sweats, your brain has already undergone the neuroadaptive changes described in this article. These symptoms indicate physical dependence, which is one component of alcohol’s broader effects on neural pathways. The severity of dependence typically increases over time, and each unsupervised withdrawal episode raises the risk of future complications through kindling.
Attempting to detox at home without medical supervision carries genuine risks, particularly for individuals with a history of seizures, previous severe withdrawal, concurrent medical conditions, or benzodiazepine co-use. Medically supervised detoxification at Phuket Island Rehab provides 24-hour clinical monitoring, CIWA-Ar-guided medication management, thiamine and nutritional supplementation, and a seamless transition into the therapeutic programme that addresses the psychological and behavioural dimensions of alcohol use disorder.
Summary
Alcohol withdrawal is a medically serious condition that follows a predictable clinical timeline from mild autonomic symptoms through potential seizures and delirium tremens. The underlying mechanism, a sudden unmasking of the brain’s compensatory hyperexcitability after chronic alcohol suppression, explains why withdrawal worsens over the first 48 to 96 hours before gradually resolving. The CIWA-Ar assessment tool enables precise, symptom-triggered pharmacological management that optimises safety while minimising medication exposure. Understanding the timeline helps patients and families prepare for what lies ahead and reinforces why medical supervision is not a luxury but a clinical necessity.
“Every patient I detoxify hears the same message,” says Dr. Ponlawat Pitsuwan. “Withdrawal is temporary, it is manageable with proper medical care, and it is the doorway to the brain recovery that follows. The discomfort of detox is the cost of reclaiming a nervous system that has been held hostage by alcohol. Most patients tell me afterward that it was far more manageable than they feared, precisely because they were monitored and treated appropriately throughout.”
Frequently Asked Questions
How long does alcohol withdrawal last?
Acute withdrawal symptoms typically peak between 24 and 72 hours after the last drink and resolve within 5 to 7 days. However, post-acute withdrawal symptoms including anxiety, sleep disturbance, and mood instability can persist for several weeks to months. The total duration depends on the severity of dependence, length of drinking history, number of previous withdrawal episodes, and individual factors including age, liver function, and co-occurring medical or psychiatric conditions.
Can you die from alcohol withdrawal?
Yes. Alcohol withdrawal is one of the few substance withdrawal syndromes that can be fatal. Untreated delirium tremens carries a mortality rate of up to 37%, primarily from cardiovascular collapse, hyperthermia, or aspiration. Withdrawal seizures can also cause fatal injuries. With modern medical management including benzodiazepine protocols, IV fluids, and continuous monitoring, mortality from DTs has been reduced to 1 to 4%. This is why medical supervision during detoxification is strongly recommended for anyone with moderate to severe alcohol dependence.
Is it safe to detox from alcohol at home?
Home detoxification may be appropriate for individuals with mild dependence (low CIWA-Ar scores, no history of seizures or DTs, no concurrent medical conditions). However, predicting withdrawal severity in advance is unreliable. Individuals who have experienced previous withdrawal episodes, drink more than 15 standard drinks daily, have co-occurring benzodiazepine use, or have a history of seizures should always detox under medical supervision. The risk of a first-time seizure during unsupervised withdrawal is the primary concern, as seizures can occur without warning even in individuals whose previous withdrawals were mild.
What medications are used during alcohol detox?
Benzodiazepines are the first-line treatment for alcohol withdrawal, with chlordiazepoxide, diazepam, and lorazepam being the most commonly used. They work by enhancing GABA-A receptor function, directly addressing the underlying neurochemical deficit. Thiamine (vitamin B1) is administered to prevent Wernicke-Korsakoff syndrome. Additional medications may include anticonvulsants like carbamazepine for seizure prevention, beta-blockers or clonidine for autonomic symptoms, and ondansetron for nausea. In severe or refractory cases, phenobarbital or propofol may be required.
What is kindling and why does it matter?
Kindling refers to the observation that repeated episodes of alcohol withdrawal become progressively more severe over time, even if the amount of alcohol consumed between episodes remains the same or decreases. Each withdrawal episode causes additional glutamate-mediated excitotoxic damage, lowering the threshold for seizures and DTs in subsequent withdrawals. Kindling is clinically significant because it means that individuals with multiple prior detoxifications face higher risks than first-time withdrawal patients and may require more aggressive pharmacological management.
What does a CIWA-Ar score mean?
The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, revised) scores withdrawal severity from 0 to 67 across 10 symptom domains. A score below 10 indicates mild withdrawal that can usually be managed with supportive care and monitoring alone. Scores of 10 to 18 indicate moderate withdrawal where symptom-triggered benzodiazepine dosing is typically initiated. Scores above 20 indicate severe withdrawal with significant risk of seizures or DTs, requiring aggressive pharmacological intervention and close medical monitoring. The tool is administered every 1 to 4 hours depending on severity and guides real-time treatment decisions.
Sources:
Jesse S, et al. “Alcohol withdrawal syndrome: mechanisms, manifestations, and management.” Acta Neurologica Scandinavica, 2017.
National Institute on Alcohol Abuse and Alcoholism (NIAAA). “Alcohol Withdrawal.” niaaa.nih.gov
Sullivan JT, et al. “Assessment of Alcohol Withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar).” British Journal of Addiction, 1989.
Sachdeva A, Choudhary M, Chandra M. “Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond.” Journal of Clinical and Diagnostic Research, 2015.
Alcohol withdrawal syndrome (AWS) | CIWA-Ar scoring | delirium tremens (DTs) | alcoholic hallucinosis | withdrawal seizures | GABA-A receptor downregulation | NMDA glutamate receptor upregulation | kindling phenomenon | excitotoxicity | benzodiazepine protocol | chlordiazepoxide | diazepam | lorazepam | thiamine (vitamin B1) | Wernicke encephalopathy | Korsakoff syndrome | post-acute withdrawal syndrome (PAWS) | autonomic hyperactivity | sympathetic nervous system | tachycardia | hypertension | hyperthermia | diaphoresis | formication | tonic-clonic seizures | medically supervised detoxification | Phuket Island Rehab